Other stories selected
Kidnappings' shatter the psyche, and the economy Similar
Mexico is living through an epoch of fear and terror, much as it did in the mid-1990’s, when the peso devaluation sparked a crime wave that made the country unlivable for many. Now Mexico is feeling the double whammy of raging drug wars - which tend not to involve innocent bystanders, but make for grisly headlines - and the more immediate threat of kidnappings, which have spread to the previously unaffected middle classes. So bad is the violence that the Mexican government expects it will shave a full point - about $10 billion - from Mexico’s economic growth this year as investors and com...Feed: Uncovering Mexico
3 days ago
Feed: bizzXceleration: Performance, ...
Value at Risk: Business Performance, Issues, News Similar
Let's wrap up the business news with some specific stories but also consideration of the broader issues that are going to increasingly challenge company performance, thru the rest of the year and likely at least 2010 ! Issues that not many appear to be anticipating nor preparing for but awareness of which will help you as an investor, employee or business partner. The readings after the break are sorted into some interesting articles on how mis-judgments about business performance are getting a lot of people in trouble followed by a section on key operational issues, including retail, manufact...Feed: bizzXceleration: Performance, ...
3 days ago
Feed: Deal Watch - The Blog
Japanese drugmaker snags Sciele Pharma in billion-dollar deal Similar
In a market where multibillion-dollar deals have become somewhat rare, Paul, Hastings, Janofsky & Walker partner Tinley Anderson in Atlanta spent the past three months working on such a deal. Sciele Pharma Inc. tapped Anderson for legal counsel on its acquisition agreement with a Japanese drugmaker. Shionogi & Co. announced today that it agreed to acquire Sciele for $1.42 billion. The price includes a cash tender offer totaling $1.1 billion and $325 million to redeem a bond convertible into shares of Sciele. Sciele, of Atlanta, markets drugs made by third parties, including the Allegra antihi...Feed: Deal Watch - The Blog







Google
Yahoo
Technorati